These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7730496)

  • 1. Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected].
    Svensson TH; Mathé JM; Andersson JL; Nomikos GG; Hildebrand BE; Marcus M
    J Clin Psychopharmacol; 1995 Feb; 15(1 Suppl 1):11S-18S. PubMed ID: 7730496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.
    Andersson JL; Nomikos GG; Marcus M; Hertel P; Mathé JM; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):374-85. PubMed ID: 8532065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs.
    Svensson TH
    Brain Res Brain Res Rev; 2000 Mar; 31(2-3):320-9. PubMed ID: 10719159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex.
    Nomikos GG; Iurlo M; Andersson JL; Kimura K; Svensson TH
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):147-56. PubMed ID: 7862887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain.
    Hertel P; Nomikos GG; Iurlo M; Svensson TH
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):74-86. PubMed ID: 8935802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons.
    Arborelius L; Chergui K; Murase S; Nomikos GG; Höök BB; Chouvet G; Hacksell U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Apr; 347(4):353-62. PubMed ID: 8510763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study.
    Blackburn TP; Minabe Y; Middlemiss DN; Shirayama Y; Hashimoto K; Ashby CR
    Synapse; 2002 Dec; 46(3):129-39. PubMed ID: 12325040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced efficacy of both typical and atypical antipsychotic drugs by adjunctive alpha2 adrenoceptor blockade: experimental evidence.
    Wadenberg ML; Wiker C; Svensson TH
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):191-202. PubMed ID: 16707032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice.
    Wang RY; Liang X
    Neuropsychopharmacology; 1998 Jul; 19(1):74-85. PubMed ID: 9608579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional mechanism of ASP5736, a selective serotonin 5-HT
    Yamazaki M; Yamamoto N; Yarimizu J; Okabe M; Moriyama A; Furutani M; Marcus MM; Svensson TH; Harada K
    Eur Neuropsychopharmacol; 2018 May; 28(5):620-629. PubMed ID: 29571967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of glutamate neurotransmission and N-methyl-d-aspartate receptor in the activation of midbrain dopamine neurons by 5-HT1A receptor agonists: an electrophysiological study in the rat.
    Gronier B
    Neuroscience; 2008 Oct; 156(4):995-1004. PubMed ID: 18801415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine blocks D-amphetamine-induced excitation of dopamine neurons in the ventral tegmental area.
    Shi WX; Zhang XY; Pun CL; Bunney BS
    Neuropsychopharmacology; 2007 Sep; 32(9):1922-8. PubMed ID: 17299514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prazosin modulates the changes in firing pattern and transmitter release induced by raclopride in the mesolimbic, but not in the nigrostriatal dopaminergic system.
    Andersson JL; Marcus M; Nomikos GG; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar; 349(3):236-43. PubMed ID: 7911558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist. I: Neurochemical and electrophysiological profile.
    Claustre Y; Peretti DD; Brun P; Gueudet C; Allouard N; Alonso R; Lourdelet J; Oblin A; Damoiseau G; Françon D; Suaud-Chagny MF; Steinberg R; Sevrin M; Schoemaker H; George P; Soubrié P; Scatton B
    Neuropsychopharmacology; 2003 Dec; 28(12):2064-76. PubMed ID: 12902994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5-HT2A sites for PCP-induced locomotion in the rat.
    Millan MJ; Brocco M; Gobert A; Joly F; Bervoets K; Rivet J; Newman-Tancredi A; Audinot V; Maurel S
    Eur J Neurosci; 1999 Dec; 11(12):4419-32. PubMed ID: 10594669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex.
    Schwieler L; Engberg G; Erhardt S
    Synapse; 2004 May; 52(2):114-22. PubMed ID: 15034917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine.
    Hertel P; Nomikos GG; Svensson TH
    Br J Pharmacol; 1997 Dec; 122(8):1639-46. PubMed ID: 9422809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle.
    Ballmaier M; Zoli M; Mazzoncini R; Gennarelli M; Spano F
    Psychopharmacology (Berl); 2001 Dec; 159(1):105-10. PubMed ID: 11797077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice.
    Gleason SD; Shannon HE
    Psychopharmacology (Berl); 1997 Jan; 129(1):79-84. PubMed ID: 9122367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of NRA0045, a novel potent antagonist at dopamine D4, 5-HT2A, and alpha1 adrenaline receptors, and NRA0160, a selective D4 receptor antagonist, on phencyclidine-induced behavior and glutamate release in rats.
    Abekawa T; Honda M; Ito K; Koyama T
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):247-56. PubMed ID: 12898123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.